Whole exome sequencing, a common genetic test, missed a large deletion on chromosome 22 in a 12-month-old girl with heart defects, severe low calcium, and repeated infections. According to Gram Research analysis of this case report, the test identified other gene mutations but failed to detect the actual cause: a missing piece of chromosome 22 (22q11.2 deletion syndrome). A follow-up test called FISH successfully found the deletion, leading to correct diagnosis and effective treatment. This case demonstrates that standard DNA sequencing has blind spots for large deletions, and doctors should use additional targeted testing when clinical features suggest a specific genetic syndrome.
A 12-month-old girl born to parents who were cousins presented with serious health problems including heart defects, severe calcium deficiency, and repeated infections. Doctors ordered a genetic test called whole exome sequencing, which found some gene changes but missed the real culprit: a missing piece of chromosome 22. According to Gram Research analysis, this case demonstrates that even advanced DNA tests have blind spots, and sometimes doctors need additional testing to find rare genetic conditions. The baby improved significantly once the correct diagnosis was made and proper treatment began.
Key Statistics
A 2026 case report in Frontiers in Pediatrics documented a 12-month-old girl whose whole exome sequencing test missed a chromosome 22 deletion but identified three other gene mutations, highlighting the technical limitations of sequencing for detecting large deletions.
Whole exome sequencing detected mutations in TTN, NEXN, and ANO5 genes in the reported case, yet failed to identify the 22q11.2 microdeletion that was the primary cause of the infant’s heart defects, low calcium levels, and immune deficiency.
A targeted FISH test successfully identified the 22q11.2 deletion in the case report, whereas the initial whole exome sequencing test did not, demonstrating that different genetic tests detect different types of mutations.
The infant in the case report showed clinical and biochemical stabilization following diagnosis and treatment with calcium supplementation, vitamin D, heart medications, and infection prevention strategies.
The Quick Take
- What they studied: A single infant case where standard genetic testing failed to identify a rare chromosomal condition, and how doctors eventually found the correct diagnosis using a different test.
- Who participated: One 12-month-old girl born to parents who were first cousins, presenting with heart problems, low calcium levels, and frequent infections.
- Key finding: Whole exome sequencing, a common genetic test, missed a large deletion on chromosome 22 but identified other gene changes. A follow-up test called FISH successfully detected the missing genetic material and confirmed the diagnosis.
- What it means for you: If your child has multiple health problems and genetic testing seems inconclusive, ask your doctor about additional tests. This case shows that one test alone may not tell the whole story, especially for rare genetic conditions.
The Research Details
This is a case report, meaning doctors documented the medical journey of a single patient to share what they learned. The infant presented to doctors with multiple serious health issues: difficulty feeding, poor growth, heart defects including a hole between heart chambers and narrowed pulmonary valve, severely low calcium levels causing muscle spasms, and repeated infections. Doctors ordered whole exome sequencing, a test that reads about 2% of a person’s DNA code, focusing on the protein-coding regions where most disease-causing mutations occur. The test found changes in three genes related to heart muscle disease and one gene related to muscle breakdown, but it did not explain all of the baby’s symptoms. Because the parents were first cousins, there was a higher chance their baby inherited the same rare genetic condition from both sides of the family, which complicated the picture. Doctors then ordered a second test called FISH (fluorescence in situ hybridization), which uses special colored probes to look for missing or extra pieces of chromosomes. This test revealed the baby was missing a large section of chromosome 22, confirming a diagnosis of 22q11.2 deletion syndrome.
This research approach matters because it shows the real-world limitations of modern genetic testing. Whole exome sequencing is fast and relatively affordable, so it is often used first when babies have unexplained health problems. However, this test cannot reliably detect large deletions or duplications of DNA. By presenting this case, the doctors highlight that clinicians need to think beyond a single test result. When a baby has classic signs of a specific genetic syndrome (like low calcium, heart defects, and immune problems), doctors should pursue additional targeted testing even if the first genetic test seems inconclusive. This lesson applies to many rare genetic conditions.
As a case report, this study documents one patient’s experience rather than comparing many patients. Case reports are lower on the evidence hierarchy than large studies, but they serve an important purpose: they alert doctors to diagnostic possibilities and highlight gaps in current testing methods. The strength of this report lies in its clear clinical documentation, the use of multiple diagnostic approaches, and the successful outcome with appropriate treatment. The main limitation is that it represents a single case, so we cannot draw broad conclusions about how often this diagnostic challenge occurs or how common this condition is in the general population.
What the Results Show
The primary finding is that whole exome sequencing failed to detect a large chromosomal deletion (22q11.2 microdeletion) in this infant, despite identifying other genetic variants. The test found mutations in three genes (TTN, NEXN, and ANO5) that are associated with heart and muscle disease, but these findings did not fully explain the baby’s clinical presentation. The baby’s symptoms were actually caused by a missing section of chromosome 22, which contains many genes important for heart development, immune function, and calcium regulation. When doctors ordered a targeted FISH test specifically looking for the 22q11.2 deletion, the test was positive, confirming the diagnosis. This finding is significant because it shows that large deletions can be missed by sequencing tests that only read individual DNA letters. The baby had classic features of 22q11.2 deletion syndrome, including heart defects (atrial septal defect and pulmonary stenosis), severe low calcium levels with muscle spasms, immune system problems leading to recurrent infections, and growth failure. Once the correct diagnosis was established, doctors implemented targeted treatment including calcium and vitamin D supplementation, heart medications, and infection prevention strategies. The baby showed clinical improvement and biochemical stabilization with this appropriate management.
A secondary but important finding was the presence of multiple genetic variants in a single patient, which is more common when parents are related. The baby carried mutations in TTN and NEXN genes, which are typically associated with cardiomyopathy (weakened heart muscle), and a mutation in ANO5, which causes a form of muscular dystrophy. These additional variants likely contributed to the severity of the baby’s heart problems and may have complicated the clinical picture. The case illustrates how parental consanguinity (being related by blood) increases the likelihood of inheriting multiple rare genetic conditions simultaneously. This finding is important for genetic counseling and for understanding why some patients have more severe or complex presentations than others with the same primary diagnosis.
This case aligns with existing medical knowledge about 22q11.2 deletion syndrome, which is known to be one of the most common microdeletion syndromes in humans, affecting approximately 1 in 2,000 to 1 in 4,000 live births. The clinical features described in this case (heart defects, low calcium, immune deficiency, and growth problems) are well-recognized hallmarks of the condition. However, this case adds to the growing body of evidence that whole exome sequencing, while useful for detecting single-gene mutations, has significant limitations for detecting structural variants like large deletions. Previous literature has documented this limitation, and this case reinforces the recommendation that clinicians should maintain a high suspicion for microdeletion syndromes based on clinical features alone, even when genetic sequencing results are inconclusive or only partially explanatory.
This is a single case report, so the findings cannot be generalized to all patients with similar presentations. The report does not provide information about how frequently this diagnostic scenario occurs or what percentage of inconclusive whole exome sequencing results are due to missed microdeletions. Additionally, the case involves consanguineous parents, which is a specific risk factor that may not apply to most patients. The report focuses on one successful diagnostic pathway but does not compare the cost-effectiveness or efficiency of different testing strategies. Finally, while the baby showed clinical improvement with treatment, the long-term outcomes and prognosis are not discussed, as this is a snapshot of the early management phase.
The Bottom Line
If your child has multiple unexplained health problems, especially involving the heart, low calcium levels, immune system issues, or growth failure, ask your doctor about testing for 22q11.2 deletion syndrome. If whole exome sequencing or other genetic tests are inconclusive but your child’s symptoms suggest a specific genetic condition, request targeted testing such as FISH or chromosomal microarray. These tests specifically look for large deletions or duplications that sequencing tests might miss. If your family has a history of consanguinity (parents are related), inform your doctor, as this increases the risk of inheriting multiple genetic conditions. Work with a multidisciplinary team including pediatric cardiologists, endocrinologists, immunologists, and genetic counselors for comprehensive management. These recommendations are based on clinical experience and case documentation rather than large randomized trials, so discuss them with your healthcare provider.
Parents and caregivers of infants with unexplained heart defects, severe low calcium levels, immune deficiency, or growth failure should pay attention to this case. Healthcare providers, especially pediatricians, neonatologists, and geneticists, should recognize the limitations of single genetic tests and maintain clinical suspicion for microdeletion syndromes. Families with a history of consanguinity should be aware of increased genetic risks. Patients with inconclusive genetic test results should not assume the testing was complete; additional targeted testing may be warranted. This case is less relevant for families without genetic risk factors or children without the specific clinical features described.
Clinical improvement in this case occurred over weeks to months with appropriate treatment including calcium supplementation, vitamin D, heart medications, and infection prevention. However, 22q11.2 deletion syndrome is a lifelong condition requiring ongoing medical management. Some complications, such as heart problems, may require surgical intervention and long-term monitoring. Immune system issues typically improve somewhat with age but may persist into adulthood. Growth and development should be monitored regularly, and the child will need multidisciplinary follow-up throughout childhood and into adulthood.
Frequently Asked Questions
Why did the genetic test miss the diagnosis if it’s supposed to find genetic problems?
Whole exome sequencing reads individual DNA letters but cannot reliably detect large missing pieces of chromosomes. The 22q11.2 deletion is a large chunk of missing DNA that requires a different type of test, like FISH or chromosomal microarray, to be detected.
What is 22q11.2 deletion syndrome and what causes it?
22q11.2 deletion syndrome occurs when a person is born missing a section of chromosome 22 containing about 40 genes. This deletion happens randomly during fetal development and affects heart, immune system, and calcium regulation. It is one of the most common genetic microdeletion syndromes.
If my child has heart problems and low calcium, could they have this syndrome?
Heart defects combined with low calcium levels are classic signs of 22q11.2 deletion syndrome, especially if accompanied by immune system problems or growth failure. Ask your doctor about testing for this condition, particularly if standard genetic tests are inconclusive.
How is 22q11.2 deletion syndrome treated?
Treatment is tailored to each child’s symptoms and may include calcium and vitamin D supplements for low calcium, heart medications or surgery for cardiac defects, antibiotics or immunizations for immune problems, and nutritional support for growth failure. A multidisciplinary medical team provides ongoing care.
Does having parents who are cousins increase the risk of genetic disorders?
Yes, when parents are related by blood, their children have a higher chance of inheriting the same rare genetic condition from both parents. This increases the likelihood of more severe or multiple genetic conditions occurring in the same child.
Want to Apply This Research?
- Track your child’s calcium levels, vitamin D supplementation, heart medication doses, and any signs of infection (fever, unusual symptoms). Record these measurements weekly or as recommended by your doctor, noting dates and values. This creates a clear record to share with your medical team and helps identify patterns.
- If your child has been diagnosed with 22q11.2 deletion syndrome, use the app to set reminders for daily calcium and vitamin D supplements, scheduled heart medications, and regular follow-up appointments with your cardiologist and endocrinologist. Create alerts for signs of infection or low calcium symptoms (muscle spasms, irritability) that warrant immediate medical attention.
- Establish a long-term tracking system that monitors growth (height and weight), calcium and vitamin D levels, heart function, and infection frequency. Review trends monthly with your healthcare provider. Track developmental milestones and any new symptoms. This ongoing documentation helps your medical team adjust treatment as your child grows and develops.
This article describes a single case report and is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. If your child has unexplained health problems, heart defects, low calcium levels, or recurrent infections, consult with a qualified healthcare provider or pediatric geneticist. Genetic testing decisions should be made in consultation with your medical team based on your child’s individual clinical presentation and family history. The information presented reflects one patient’s experience and may not apply to all individuals with similar symptoms.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.